Genetically predicted exposure | Outcome data | N of overlapping SNPs | MR-Egger intercept P value | MR methods | Estimated beta | Estimated standard error | Estimated P value |
---|---|---|---|---|---|---|---|
Creatinine-based eGFR | UK Biobank | 140 | 0.359 | Inverse variance weighted | − 0.121 | 0.544 | 0.824 |
Weighted median | 0.578 | 0.553 | 0.296 | ||||
MR-Egger | 1.056 | 1.390 | 0.449 | ||||
CARDIoGRAMplusC4D | 137 | 0.183 | Inverse variance weighted | 0.380 | 0.497 | 0.445 | |
Weighted median | 0.279 | 0.510 | 0.585 | ||||
MR-Egger | 1.985 | 1.297 | 0.128 | ||||
Cystatin C-based eGFR | UK Biobank | 347 | 0.618 | Inverse variance weighted | − 0.289 | 0.350 | 0.409 |
Weighted median | 0.183 | 0.460 | 0.690 | ||||
MR-Egger | − 0.022 | 0.639 | 0.971 | ||||
CARDIoGRAMplusC4D | 341 | 0.697 | Inverse variance weighted | 0.062 | 0.316 | 0.845 | |
Weighted median | − 0.286 | 0.376 | 0.448 | ||||
MR-Egger | − 0.135 | 0.598 | 0.821 |